Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Cyclopentolate hydrochloride
Drug ID BADD_D00548
Description A parasympatholytic anticholinergic used solely to obtain mydriasis or cycloplegia.
Indications and Usage Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.
Marketing Status approved
ATC Code S01FA04
DrugBank ID DB00979
KEGG ID D01002
MeSH ID D003519
PubChem ID 22162
TTD Drug ID D0B1EV
NDC Product Code 0065-0396; 17478-096; 61314-396; 38779-0848; 82133-100; 42385-105; 24208-735; 0065-0397; 17478-100; 49452-2403; 17478-097; 0065-0395
UNII 736I6971TE
Synonyms Cyclopentolate | Cyclogyl
Chemical Information
Molecular Formula C17H26ClNO3
CAS Registry Number 60452-46-2
SMILES CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O.Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Aptyalism07.06.01.001--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Coma17.02.09.001--Not Available
Conjunctivitis11.01.06.012; 06.04.01.002--
Death08.04.01.001--
Disorientation19.13.01.002; 17.02.05.015--Not Available
Hallucination19.10.04.003--
Hyperaemia24.03.02.002--Not Available
Hyperpyrexia08.05.02.002--Not Available
Incoherent19.10.03.006; 17.02.08.002--Not Available
Intraocular pressure increased13.07.04.002--Not Available
Iris adhesions06.06.06.003--Not Available
Paralysis17.01.04.004--Not Available
Photophobia17.17.02.006; 06.01.01.004--
Psychomotor hyperactivity19.11.02.003; 17.01.02.011--Not Available
Punctate keratitis06.04.02.003--Not Available
Rash23.03.13.001--Not Available
Restlessness17.02.05.021; 19.11.02.002--
Seizure17.12.03.001--
Skin irritation23.03.04.009--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Sweat gland disorder23.02.03.010--Not Available
Tachycardia02.03.02.007--Not Available
Urinary retention20.02.02.011--
Vision blurred17.17.01.010; 06.02.06.007--
Allergic bronchitis22.03.02.002; 10.01.03.026--Not Available
Cognitive disorder17.03.03.003; 19.21.02.001--
Vasodilation procedure25.03.01.001--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages